BillionToOne - JPM Presentation 2026.pdf

1、Redefining Molecular Diagnostics with Single-Molecule PrecisionJPM Healthcare Conference 20262025 Q3 Business UpdateThis presentation contains certain“forward-looking statements within the meaning of applicable securities laws.These statements relate to future events and results of BillionToOne,Inc.

2、(the“Company,“we,“us,or“our)and involve known and unknown risks,uncertainties and other factors that may cause the actual results,levels of activity,performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements

3、.In some cases,forward-looking statements can be identified by terminology such as“may,“will,“could,“would,“should,“to,“target,“expect,“plan,“anticipate,“intend,“believe,“estimate,“predict,“potential or other comparable terminology.All statements other than statements of historical fact could be dee

4、med forward-looking,including,but not limited to:our fourth quarter and full years 2025 and 2026 guidance,any projections of market opportunities;any statements regarding expectations for future reimbursement opportunities and health system adoption;any statements regarding the Companys long-term ex

5、pectations;and the Companys goals and general business and market conditions.The forward-looking statements are based on our beliefs,assumptions and expectations of future performance,taking into account the information currently available to us.These statements are only predictions based upon our c

6、urrent expectations about future events.Forward-looking statements are subject to known and unknown risks,uncertainties and other factors that may cause our actual results,performance or achievements to be materially different from those expressed or implied by such forward-looking statements includ